Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
Identifieur interne : 001F45 ( Main/Curation ); précédent : 001F44; suivant : 001F46Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
Auteurs : Sébastien Robert Montel [France] ; Catherine BungenerSource :
- Surgical neurology [ 1879-3339 ] ; 2009.
English descriptors
- KwdEn :
- Adaptation, Psychological, Adult, Aged, Aged, 80 and over, Antiparkinson Agents (therapeutic use), Anxiety (etiology), Cognition, Deep Brain Stimulation (adverse effects), Depression (etiology), Dopamine Agonists (therapeutic use), Female, Humans, Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (psychology), Parkinson Disease (therapy), Patient Education as Topic, Psychomotor Performance, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Time Factors.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Levodopa.
- adverse effects : Deep Brain Stimulation.
- drug therapy : Parkinson Disease.
- etiology : Anxiety, Depression.
- psychology : Parkinson Disease.
- therapy : Parkinson Disease.
- Adaptation, Psychological, Adult, Aged, Aged, 80 and over, Cognition, Female, Humans, Male, Middle Aged, Patient Education as Topic, Psychomotor Performance, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Time Factors.
Abstract
Although the positive effect of DBS of the STN on motor signs and mobility in PD is indisputable, the effect on mental health (depression and anxiety) as well as on QoL is subject to more debate. Some works have already shown that coping strategies have an impact on QoL, depression, and anxiety. To date, no studies have examined the coping strategies used by patients with PD who undergo STN stimulation. We decided to investigate the coping strategies of patients with PD who have undergone an STN DBS and their relationship with QoL while taking depression and anxiety into account.
DOI: 10.1016/j.surneu.2008.05.026
PubMed: 18786708
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000B75
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000B35
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000B35
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000899
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000899
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000899
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002098
Links to Exploration step
pubmed:18786708Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.</title><author><name sortKey="Montel, Sebastien Robert" sort="Montel, Sebastien Robert" uniqKey="Montel S" first="Sébastien Robert" last="Montel">Sébastien Robert Montel</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Clinical Psychopathology and Neuropsychology, University Paris Descartes, France. montel.sebastien@wanadoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Clinical Psychopathology and Neuropsychology, University Paris Descartes</wicri:regionArea><wicri:noRegion>University Paris Descartes</wicri:noRegion><wicri:noRegion>University Paris Descartes</wicri:noRegion></affiliation></author><author><name sortKey="Bungener, Catherine" sort="Bungener, Catherine" uniqKey="Bungener C" first="Catherine" last="Bungener">Catherine Bungener</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:18786708</idno><idno type="pmid">18786708</idno><idno type="doi">10.1016/j.surneu.2008.05.026</idno><idno type="wicri:Area/PubMed/Corpus">000B75</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B75</idno><idno type="wicri:Area/PubMed/Curation">000B35</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B35</idno><idno type="wicri:Area/PubMed/Checkpoint">000B35</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B35</idno><idno type="wicri:Area/Ncbi/Merge">000899</idno><idno type="wicri:Area/Ncbi/Curation">000899</idno><idno type="wicri:Area/Ncbi/Checkpoint">000899</idno><idno type="wicri:Area/Main/Merge">002098</idno><idno type="wicri:Area/Main/Curation">001F45</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.</title><author><name sortKey="Montel, Sebastien Robert" sort="Montel, Sebastien Robert" uniqKey="Montel S" first="Sébastien Robert" last="Montel">Sébastien Robert Montel</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Clinical Psychopathology and Neuropsychology, University Paris Descartes, France. montel.sebastien@wanadoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Clinical Psychopathology and Neuropsychology, University Paris Descartes</wicri:regionArea><wicri:noRegion>University Paris Descartes</wicri:noRegion><wicri:noRegion>University Paris Descartes</wicri:noRegion></affiliation></author><author><name sortKey="Bungener, Catherine" sort="Bungener, Catherine" uniqKey="Bungener C" first="Catherine" last="Bungener">Catherine Bungener</name></author></analytic><series><title level="j">Surgical neurology</title><idno type="eISSN">1879-3339</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptation, Psychological</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antiparkinson Agents (therapeutic use)</term><term>Anxiety (etiology)</term><term>Cognition</term><term>Deep Brain Stimulation (adverse effects)</term><term>Depression (etiology)</term><term>Dopamine Agonists (therapeutic use)</term><term>Female</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (psychology)</term><term>Parkinson Disease (therapy)</term><term>Patient Education as Topic</term><term>Psychomotor Performance</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Surveys and Questionnaires</term><term>Time Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Deep Brain Stimulation</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anxiety</term><term>Depression</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adaptation, Psychological</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cognition</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Education as Topic</term><term>Psychomotor Performance</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Surveys and Questionnaires</term><term>Time Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although the positive effect of DBS of the STN on motor signs and mobility in PD is indisputable, the effect on mental health (depression and anxiety) as well as on QoL is subject to more debate. Some works have already shown that coping strategies have an impact on QoL, depression, and anxiety. To date, no studies have examined the coping strategies used by patients with PD who undergo STN stimulation. We decided to investigate the coping strategies of patients with PD who have undergone an STN DBS and their relationship with QoL while taking depression and anxiety into account.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001F45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:18786708
|texte= Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:18786708" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |